Management Team

Sanjay Nayak, MBBS, PhD, was the founder and fund manager of a biotech-focused private investment fund, Sentiv Capital. The fund invested in public and private biotechnology companies and has been a sought-after co-investor, based on the quality and depth of his due diligence and contributions to investment strategy. Dr. Nayak’s investment approach integrated more than 20 years of expertise in retina and ophthalmology with strong connections spanning industry, the investment community and top key opinion leaders, as well as a unique strategic acuity related to healthcare markets. Prior to founding Sentiv Capital, Dr. Nayak was the founder and Managing Partner at AnalyzeRx LLC, a well-respected healthcare consulting practice focused on delivering customized, high-end, qualitative market analytics and competitive strategy to large-cap pharmaceutical and biotechnology companies.

The firm developed a differentiated perspective on retinal therapeutics and provided competitive analysis, strategic guidance and supported the business development needs of its clients for more than fifteen years. Prior to his work at Analyze Rx LLC, Dr. Nayak was a Director at Strategic Analysis, Healthcare, which was acquired by IMS Health. His consulting work was focused on pharmaceutical competitive analysis encompassing commercial launch preparations and regulatory, pipeline and clinical trial evaluations. Dr. Nayak received his medical degree (MBBS) from Grant Medical College, University of Bombay, India and earned a PhD in pharmacology from Drexel University, Philadelphia, Pennsylvania. He is the author or co-author on several publications related to presynaptic receptors in the brain.